Spots Global Cancer Trial Database for hlx53 (1000mg)
Every month we try and update this database with for hlx53 (1000mg) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 With or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. | NCT06349980 | Carcinoma, Hepa... | HLX53 (1000mg) HLX53 (2000mg) HLX10 HLX04 Placebo | 18 Years - | Shanghai Henlius Biotech | |
A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 With or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. | NCT06349980 | Carcinoma, Hepa... | HLX53 (1000mg) HLX53 (2000mg) HLX10 HLX04 Placebo | 18 Years - | Shanghai Henlius Biotech |